• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征诊断标准的德尔菲共识

Delphi consensus on the diagnostic criteria of polycystic ovary syndrome.

作者信息

Facchinetti Fabio, Gambineri Alessandra, Aimaretti Gianluca, Ferlin Alberto, Laganà Antonio Simone, Moghetti Paolo, Montanino Oliva Mario, Unfer Vittorio, Colao Annamaria

机构信息

The Experts Group on Inositol in Basic and Clinical Research (EGOI), Rome, Italy.

University of Modena and Reggio Emilia, Modena, Italy.

出版信息

J Endocrinol Invest. 2025 Jan 20. doi: 10.1007/s40618-025-02533-4.

DOI:10.1007/s40618-025-02533-4
PMID:39831926
Abstract

PURPOSE

To gather the current opinion among Italian gynecologists and endocrinologists regarding the definition, diagnosis, and treatment of polycystic ovary syndrome (PCOS).

METHOD

A Delphi survey consisting of 26 statements was designed by a nine-member panel (consisting of members from the Italian Society of Endocrinology (SIE) and the Experts Group AQon Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS)) and distributed to 102 experts in PCOS across the fields of gynecology and endocrinology. Consensus was defined as an agreement between at least 70% of responders. Participants completed three rounds of statements, ranking their level of agreement.

RESULTS

Of the initial 26 statements, 25 reached an adequate consensus, with an overall response rate of 73%. The statements were divided into three sections: definition and current understanding, diagnosis, and treatment. Of the statements that reached consensus, near total agreement was reached in the first two sections, whereas there was a divergence of opinion in terms of optimum treatment strategy between the gynecology and endocrinology subgroups.

CONCLUSION

It was agreed that the current clinical guidelines are inadequate for clinical and scientific practice, with most responders advocating for the inclusion of metabolic factors. Furthermore, the consensus opinion advocated for the diversification of hyperandrogenic vs. non-hyperandrogenic phenotypes. This survey gives a snapshot of the current understanding of PCOS in the Italian healthcare community.

摘要

目的

收集意大利妇科医生和内分泌学家关于多囊卵巢综合征(PCOS)的定义、诊断和治疗的当前观点。

方法

由一个由九名成员组成的小组(包括来自意大利内分泌学会(SIE)以及基础和临床研究及PCOS领域的肌醇AQon专家小组(EGOI-PCOS)的成员)设计了一项包含26条陈述的德尔菲调查,并分发给102名妇科和内分泌领域的PCOS专家。共识被定义为至少70%的受访者达成一致。参与者完成三轮陈述,对他们的同意程度进行排名。

结果

在最初的26条陈述中,25条达成了充分的共识,总体回复率为73%。这些陈述分为三个部分:定义和当前理解、诊断和治疗。在达成共识的陈述中,前两个部分几乎完全达成一致,而妇科和内分泌亚组在最佳治疗策略方面存在意见分歧。

结论

大家一致认为,当前的临床指南不足以用于临床和科学实践,大多数受访者主张纳入代谢因素。此外,共识意见主张区分高雄激素血症与非高雄激素血症表型。这项调查展示了意大利医疗界对PCOS的当前理解。

相似文献

1
Delphi consensus on the diagnostic criteria of polycystic ovary syndrome.多囊卵巢综合征诊断标准的德尔菲共识
J Endocrinol Invest. 2025 Jan 20. doi: 10.1007/s40618-025-02533-4.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Global Delphi consensus on treatment goals for generalized pustular psoriasis.关于泛发性脓疱型银屑病治疗目标的全球德尔菲共识。
Br J Dermatol. 2025 Mar 18;192(4):706-716. doi: 10.1093/bjd/ljae491.
4
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征的患病率及表型特征:一项系统评价与荟萃分析
Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22.
5
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.多囊卵巢综合征女性的卵巢手术以缓解症状
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD009526. doi: 10.1002/14651858.CD009526.pub2.
6
Expert consensus on solutions to improve implementation of NICE type 2 diabetes guideline (NG28) by health systems in England: a Delphi panel by the INNOVATE-28 Working Group.关于英格兰卫生系统改进国家卫生与临床优化研究所2型糖尿病指南(NG28)实施情况的解决方案的专家共识:创新28工作组的德尔菲小组。
BMJ Open. 2025 Jun 26;15(6):e093955. doi: 10.1136/bmjopen-2024-093955.
7
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
8
Standardizing the Definition of Each Colon Cancer Segment: Delphi Consensus on Clinical Decision-Making for Oncologic Outcomes.规范各结肠癌节段的定义:关于肿瘤学结局临床决策的德尔菲共识
Dis Colon Rectum. 2025 Apr 11. doi: 10.1097/DCR.0000000000003739.
9
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.用于多囊卵巢综合征不孕女性的中草药
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD007535. doi: 10.1002/14651858.CD007535.pub3.
10
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征中中度和重度抑郁及焦虑症状的高患病率:一项系统评价和荟萃分析。
Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044.

引用本文的文献

1
Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model.认识胰岛素抵抗在多囊卵巢综合征中的作用:从以葡萄糖为中心的方法到以胰岛素为中心的模型的范式转变。
J Clin Med. 2025 Jun 6;14(12):4021. doi: 10.3390/jcm14124021.

本文引用的文献

1
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire.欧洲多囊卵巢综合征的诊断和管理调查:ESE PCOS 特别兴趣小组 2023 年问卷的完整报告。
Eur J Endocrinol. 2024 Aug 5;191(2):134-143. doi: 10.1093/ejendo/lvae085.
2
Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women's Endocrinology.肌醇与女性生殖障碍:意大利内分泌学会(SIE)-女性内分泌学工作组的共识声明。
J Endocrinol Invest. 2024 Sep;47(9):2111-2141. doi: 10.1007/s40618-024-02363-w. Epub 2024 Jul 15.
3
Has the name PCOS run its course?
多囊卵巢综合征(PCOS)这个名称是否已完成其使命?
Arch Gynecol Obstet. 2024 Sep;310(3):1761-1762. doi: 10.1007/s00404-024-07571-6. Epub 2024 Jun 5.
4
Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review.多囊卵巢综合征的诊断、管理及相关合并症:一项叙述性综述
Cureus. 2024 Apr 22;16(4):e58733. doi: 10.7759/cureus.58733. eCollection 2024 Apr.
5
PCOS phenotype focus: phenotype D under the magnifying glass.多囊卵巢综合征表型关注点:显微镜下的表型 D。
Arch Gynecol Obstet. 2024 Jun;309(6):2307-2313. doi: 10.1007/s00404-024-07408-2. Epub 2024 Mar 19.
6
Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess.多囊卵巢综合征中的主导因素与次要因素:胰岛素抵抗与雄激素过多。
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1680-1681. doi: 10.1111/aogs.14802. Epub 2024 Feb 10.
7
The Impact of Irregular Menstruation on Health: A Review of the Literature.月经不调对健康的影响:文献综述
Cureus. 2023 Nov 20;15(11):e49146. doi: 10.7759/cureus.49146. eCollection 2023 Nov.
8
Questioning PCOS phenotypes for reclassification and tailored therapy.对多囊卵巢综合征(PCOS)表型进行重新分类和个体化治疗的质疑。
Trends Endocrinol Metab. 2023 Nov;34(11):694-703. doi: 10.1016/j.tem.2023.08.005. Epub 2023 Sep 1.
9
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见。
Fertil Steril. 2023 Oct;120(4):767-793. doi: 10.1016/j.fertnstert.2023.07.025. Epub 2023 Aug 14.
10
Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review.肌醇与二甲双胍治疗多囊卵巢综合征的系统评价
Cureus. 2023 Jul 11;15(7):e41748. doi: 10.7759/cureus.41748. eCollection 2023 Jul.